Steroid-sparing effect of belimumab: results from a retrospective observational study of real-world data.
Karen WorleyScott MilliganBernard RubinPublished in: Lupus science & medicine (2023)
This analysis showed significant reductions in OCS dose and use in patients with SLE who persisted with belimumab, providing more real-world evidence for belimumab's steroid-sparing effect.